| LINE ITEM (USD / %) | FY 2025
FILED 2025-10-04 | FY 2024
FILED 2024-09-28 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $654.1M | $706.2M | $742.5M |
| YoY Revenue Growth % | -7.4% | -4.9% | — |
| Gross Profit | $277.9M | $268.8M | — |
| Gross Margin % | 42.5% | 38.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.2M | -$92.5M | $39.4M |
| Operating Margin % | -0.5% | -13.1% | 5.3% |
| Net Income (GAAP) | $213.0K | -$69.0M | $57.1M |
| EBITDA (Normalized) | $10.5M | -$79.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $113.6M | $31.0M | $173.4M |
| Capital Expenditures (CapEx) | $17.2M | $16.1M | — |
| Free Cash Flow (FCF) | $96.4M | $14.9M | $173.4M |
| FCF Margin % | 14.7% | 2.1% | 23.4% |
| Return on Invested Capital (ROIC %) | -0.5% | -10.5% | — |
| Cash & Short-Term Equivalents | $282.1M | $278.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $825.0M | $972.7M | — |